Embecta to Report 2026 Results With 2027 Guidance on November 24
Embecta will report its fiscal fourth-quarter and full-year 2026 results before the market opens on November 24, 2026, and hold a conference call at 8 a.m. ET. The company plans to provide an operational update and preliminary fiscal 2027 guidance, followed by a question-and-answer session; the webcast replay will be available on its investor relations website. Analysts cited in one report expect quarterly earnings of 31 cents per share and revenue of about $267.4 million. Embecta is seeking to expand beyond its insulin-delivery heritage into a broader medical supplies business.
How it spread
Claim check
What each side asserts, disputes — or leaves out entirely.
Where do you land?
Whose framing of this story rings truest to you?






